Cargando…
Corrigendum: Research on the mechanism and prevention of hypertension caused by apatinib through the RhoA/ROCK signaling pathway in a mouse model of gastric cancer
Autores principales: | Wang, Wenjuan, Li, Caie, Zhuang, Chenchen, Zhang, Haodong, Wang, Qiongying, Fan, Xin, Qi, Miaomiao, Sun, Runmin, Yu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647171/ https://www.ncbi.nlm.nih.gov/pubmed/36386320 http://dx.doi.org/10.3389/fcvm.2022.1070597 |
Ejemplares similares
-
Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer
por: Wang, Wenjuan, et al.
Publicado: (2022) -
A narrative review on the interaction between genes and the treatment of hypertension and breast cancer
por: Wang, Wenjuan, et al.
Publicado: (2021) -
Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension
por: Li, Caie, et al.
Publicado: (2022) -
Corrigendum: Cardiovascular risk according to body mass index in reproductive-aged women with polycystic ovary syndrome: a systematic review and meta-analysis
por: Zhuang, Chenchen, et al.
Publicado: (2023) -
Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Zhuang, Chenchen, et al.
Publicado: (2022)